Bannari Amman Sugars Limited
Our verdict
Valuation (73/100) does the heavy lifting; momentum (15/100) is the drag.
Our fair value
Undervalued by 46%Buy-below (20% margin of safety): ₹3,611.13
Our blended model reads Bannari Amman Sugars Limited as a Hold at 49/100. At ₹3,100.2 it trades below our blended DCF and relative-multiples fair value of ₹4,513.91, about 46% upside to that estimate — we read it as undervalued by 46%. On 29.4x trailing earnings it sits pricier than the Consumer Defensive median of about 26.1x. It's sitting close to its 52-week low of ₹3,095.2. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. It clears 7 of 13 investability checks, with durability 53, valuation 45 and momentum 15 on our 0–100 scales.
Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹3,611.13.
1-year price
EOD · 2026-11-2052-week range
-26.63% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold49Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 8.0%
- Pass: Low debt (D/E < 0.5): 0.00x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: -43%
- Pass: Earnings growing: 18%
- Fail: Net margin ≥ 10%: 7.7%
- Pass: Current ratio > 1.5: 7.83
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 11.2
- Fail: Piotroski ≥ 7: 5/9
Shareholding
- Promoter83.1%
- Institutions4.1%
- Public & other12.7%
Promoter holding via insider stake; institutional via reported holdings.
Superstar investors in Bannari Amman Sugars Limited
Named in the company's June 2026 shareholding filing with the exchanges.
All superstar portfolios →Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 11.2.
Opportunities
- Earnings growing (18% YoY).
- Trades ~46% below our estimated fair value.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
About Bannari Amman Sugars Limited
Bannari Amman Sugars Limited manufactures and sells sugar and related products in India across four business segments: sugar operations, power generation, distillery production, and granite products. The company produces cane crush, industrial alcohol, extra neutral spirits, polished granite, and agricultural inputs including fertilizers, fungicides, insecticides, nematicides, stimulants, and organic manures.
Bannari Amman Sugars Limited — frequently asked questions
Is Bannari Amman Sugars Limited a buy, hold or sell?
TickerMagic currently rates Bannari Amman Sugars Limited (BANARISUG) a Hold, based on a blended score of 49/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Bannari Amman Sugars Limited's fair value?
Our blended DCF and relative-valuation model estimates Bannari Amman Sugars Limited's fair value at about ₹4,513.91, versus a current price of ₹3,100.2 — roughly 46% upside. On that basis the stock looks undervalued by 46%.
Is Bannari Amman Sugars Limited financially healthy?
Bannari Amman Sugars Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has Bannari Amman Sugars Limited's share price performed?
Bannari Amman Sugars Limited is down 12% over three months, and last traded at ₹3,100.2. Past performance doesn't predict future returns.
More in Consumer Defensive
Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.